Orphenadrine Plus Paracetamol: Dosing and Contraindications
The standard adult dose for orphenadrine plus paracetamol combination is one tablet containing 35-50 mg orphenadrine and 325-450 mg paracetamol, taken 3 times daily, with absolute contraindications including tachycardia, cardiac arrhythmias, coronary insufficiency, cardiac decompensation, and glaucoma.
Recommended Dosing
Oral Combination Therapy
- Standard dose: 1 tablet containing orphenadrine 35-50 mg plus paracetamol 325-450 mg, administered 3 times daily 1, 2
- Maximum paracetamol: Do not exceed 4 g/day total paracetamol from all sources 3
- FDA guidance: Combination products should limit paracetamol to ≤325 mg per dosage unit to reduce hepatotoxicity risk 4
Parenteral Orphenadrine (when combination not available)
- IV/IM dose: 60 mg (one 2 mL vial) every 12 hours 5
- Transition: May switch to oral orphenadrine 100 mg tablets twice daily for maintenance 5
Critical Dosing Considerations
The combination demonstrates superior analgesic efficacy compared to paracetamol alone, with statistically significant pain relief beginning on day 2-3 of treatment 1, 2. When using fixed-dose combinations, you must account for total paracetamol intake from all sources - this is a common pitfall that leads to inadvertent overdosing 4, 6, 4.
Absolute Contraindications
Cardiac conditions 5:
- Tachycardia
- Cardiac arrhythmias
- Coronary insufficiency
- Cardiac decompensation
Other absolute contraindications:
- Glaucoma (orphenadrine has anticholinergic effects) 5
- Known hypersensitivity to orphenadrine or paracetamol 4
Relative Contraindications and Cautions
Hepatic Considerations
- Liver disease/cirrhosis: Use paracetamol with extreme caution; reduce dose to 2-3 g/day maximum 3, 7
- Chronic alcohol use: Limit paracetamol to 2-3 g/day despite older concerns about 4 g dosing 7
- Active liver failure: Paracetamol should be avoided or used at significantly reduced doses 3
Renal Impairment
- Exercise caution with paracetamol in chronic kidney disease 6
- Monitor renal function if prolonged use is necessary
Drug Interactions
- Propoxyphene: Concomitant use may cause confusion, anxiety, and tremors; reduce dosage or discontinue one agent 5
- Warfarin/anticoagulants: Monitor closely due to paracetamol effects on INR
- Other anticholinergic medications: Additive anticholinergic effects possible
Special Populations
- Pregnancy: Category C - use only if clearly needed 5
- Pediatric: Safety not established; not recommended in children 5
- Elderly: Use with caution due to anticholinergic effects and increased fall risk
Monitoring Requirements
For prolonged therapy (though long-term safety is not established) 5:
- Periodic blood counts
- Liver function tests
- Renal function tests
- Urinalysis
Clinical Efficacy Context
The combination of orphenadrine and paracetamol is specifically effective for musculoskeletal pain with muscle spasm, particularly myalgia and cervical/thoracic muscle tension 1, 2, 8. The orphenadrine component provides both muscle relaxant and mild analgesic properties, while paracetamol contributes additional analgesia 8. This combination shows superior efficacy over paracetamol alone in controlled trials, with pain relief evident within 30 minutes and sustained through 6 hours 9.
Key Clinical Pitfalls to Avoid
- Paracetamol stacking: Always calculate total daily paracetamol from combination products, over-the-counter medications, and other prescriptions
- Cardiac screening: Screen for cardiac contraindications before prescribing orphenadrine
- Anticholinergic burden: Avoid in patients already taking multiple anticholinergic medications
- Duration misconception: This is for acute/subacute pain management, not chronic long-term therapy
- Alcohol history: Actively inquire about alcohol use to adjust paracetamol dosing appropriately